Chicago Cubs: 8-time All-Star suspended for 2021 season after positive PED test
|Wednesday, November 18, 2020, 3:46 PM-|
The Office of the Commissioner of Baseball announced today that New York Mets second baseman Robinson Canó has received a 162-game suspension without pay after testing positive for Stanozolol, a performance-enhancing substance, in violation of Major League Baseball’s Joint Drug Prevention and Treatment Program.
The suspension of Canó, who was previously suspended for a violation of the Program on May 15, 2018, will commence at the start of the 2021 regular season.
BREAKING: New York Mets second baseman Robinson Cano has tested positive for a performance-enhancing drug and will be suspended for the entire 2021 season, sources familiar with the situation tell ESPN. He will forfeit a $24 million salary. News story will be up soon at ESPN.— Jeff Passan (@JeffPassan) November 18, 2020
Well, this Cano news gives the Mets the opening to move Jeff McNeil to what many feel is his best position, second base. It frees up more money for various pursuits and might well mean that Robinson Cano never plays for the Mets again. Shameful development.— Howie Rose (@HowieRose) November 18, 2020
It takes a special amount of stupidity and arrogance to test positive for steroids in 2020 as an established player. Minor leaguers and fringe players who are clinging to jobs as professional baseball players, I get it. Robinson Cano not once but twice? I will never understand.— Jared Carrabis (@Jared_Carrabis) November 18, 2020
Suddenly the Mets just got Stroman for free in 2021 + $5,100,000 to spare. #RobinsonCano— The 7 Line (@The7Line) November 18, 2020
That Brodie Van Wagenen trade for Robinson Cano looks even worse now. And that’s saying something.— Marc Carig (@MarcCarig) November 18, 2020
Breaking: New York Mets second baseman Robinson Cano tested positive for a performance-enhancing drug and will be suspended for the entire 2021 season. pic.twitter.com/luKnnfCU4K— SportsCenter (@SportsCenter) November 18, 2020